Fresenius Medical Care Midwest Lakeshore is a medicare approved dialysis facility center in Saint Francis, Wisconsin and it has 10 dialysis stations. It is located in Milwaukee county at 2000 E Layton Ave Ste 200, Saint Francis, WI, 53235. You can reach out to the office of Fresenius Medical Care Midwest Lakeshore at (414) 481-7179. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fresenius Medical Care Midwest Lakeshore has the following ownership type - Profit. It was first certified by medicare in June, 2004. The medicare id for this facility is 522561 and it accepts patients under medicare ESRD program.
| Name | Fresenius Medical Care Midwest Lakeshore |
|---|---|
| Location | 2000 E Layton Ave Ste 200, Saint Francis, Wisconsin |
| No. of Dialysis Stations | 10 |
| Medicare ID | 522561 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 2000 E Layton Ave Ste 200, Saint Francis, Wisconsin, 53235 | |
| (414) 481-7179 | |
News Archive
"American Hospital Association, which represents nearly 5,000 hospitals, spent $3.7 million lobbying the federal government in the first quarter on Medicare, health care reform and a host of other topics," which included "Medicare fraud prevention, a requirement for minimum nurse staffing rations for some Medicare providers and a bill that provides for the application of a consistent part B premium for all Medicare beneficiaries, according to a 34-page lobbying report filed with the clerk of the House of Representatives…
The Wall Street Journal: "After years of frustration, workers sickened in the recovery and cleanup efforts after the Sept. 11 terrorist attacks are on the verge of getting paid for their illnesses. Yet the proposed legal settlement of up to $712 million also would pay money to thousands of people who aren't sick at all. That's just one of the concerns that could scuttle the proposed deal, which requires approval of 95% of those suing for compensation."
Scientists at The Rockefeller University have mapped the three-dimensional structure for one of the more notorious disease-causing molecules in the human body: the protein responsible for the genetic disorder cystic fibrosis. And it looks fishy.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Vertex Pharmaceuticals has announced that its collaborator, GlaxoSmithKline (GSK), has received fast track designation for the HIV protease inhibitor (PI) 640385 (VX-385) from the United States Food and Drug Administration.
› Verified 2 days ago
| NPI Number | 1134465917 |
| Organization Name | Fresenius Medical Care Midwest Lakeshore |
| Doing Business As | Fresenius Medical Care Midwest Dialysis, Llc |
| Address | 2000 E Layton Ave St Francis, Wisconsin, 53235 |
| Phone Number | (414) 744-4343 |
News Archive
"American Hospital Association, which represents nearly 5,000 hospitals, spent $3.7 million lobbying the federal government in the first quarter on Medicare, health care reform and a host of other topics," which included "Medicare fraud prevention, a requirement for minimum nurse staffing rations for some Medicare providers and a bill that provides for the application of a consistent part B premium for all Medicare beneficiaries, according to a 34-page lobbying report filed with the clerk of the House of Representatives…
The Wall Street Journal: "After years of frustration, workers sickened in the recovery and cleanup efforts after the Sept. 11 terrorist attacks are on the verge of getting paid for their illnesses. Yet the proposed legal settlement of up to $712 million also would pay money to thousands of people who aren't sick at all. That's just one of the concerns that could scuttle the proposed deal, which requires approval of 95% of those suing for compensation."
Scientists at The Rockefeller University have mapped the three-dimensional structure for one of the more notorious disease-causing molecules in the human body: the protein responsible for the genetic disorder cystic fibrosis. And it looks fishy.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Vertex Pharmaceuticals has announced that its collaborator, GlaxoSmithKline (GSK), has received fast track designation for the HIV protease inhibitor (PI) 640385 (VX-385) from the United States Food and Drug Administration.
› Verified 2 days ago
| Dialysis patients with Hemoglobin data | 20 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 10 |
News Archive
"American Hospital Association, which represents nearly 5,000 hospitals, spent $3.7 million lobbying the federal government in the first quarter on Medicare, health care reform and a host of other topics," which included "Medicare fraud prevention, a requirement for minimum nurse staffing rations for some Medicare providers and a bill that provides for the application of a consistent part B premium for all Medicare beneficiaries, according to a 34-page lobbying report filed with the clerk of the House of Representatives…
The Wall Street Journal: "After years of frustration, workers sickened in the recovery and cleanup efforts after the Sept. 11 terrorist attacks are on the verge of getting paid for their illnesses. Yet the proposed legal settlement of up to $712 million also would pay money to thousands of people who aren't sick at all. That's just one of the concerns that could scuttle the proposed deal, which requires approval of 95% of those suing for compensation."
Scientists at The Rockefeller University have mapped the three-dimensional structure for one of the more notorious disease-causing molecules in the human body: the protein responsible for the genetic disorder cystic fibrosis. And it looks fishy.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Vertex Pharmaceuticals has announced that its collaborator, GlaxoSmithKline (GSK), has received fast track designation for the HIV protease inhibitor (PI) 640385 (VX-385) from the United States Food and Drug Administration.
› Verified 2 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 54 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 520 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
"American Hospital Association, which represents nearly 5,000 hospitals, spent $3.7 million lobbying the federal government in the first quarter on Medicare, health care reform and a host of other topics," which included "Medicare fraud prevention, a requirement for minimum nurse staffing rations for some Medicare providers and a bill that provides for the application of a consistent part B premium for all Medicare beneficiaries, according to a 34-page lobbying report filed with the clerk of the House of Representatives…
The Wall Street Journal: "After years of frustration, workers sickened in the recovery and cleanup efforts after the Sept. 11 terrorist attacks are on the verge of getting paid for their illnesses. Yet the proposed legal settlement of up to $712 million also would pay money to thousands of people who aren't sick at all. That's just one of the concerns that could scuttle the proposed deal, which requires approval of 95% of those suing for compensation."
Scientists at The Rockefeller University have mapped the three-dimensional structure for one of the more notorious disease-causing molecules in the human body: the protein responsible for the genetic disorder cystic fibrosis. And it looks fishy.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Vertex Pharmaceuticals has announced that its collaborator, GlaxoSmithKline (GSK), has received fast track designation for the HIV protease inhibitor (PI) 640385 (VX-385) from the United States Food and Drug Administration.
› Verified 2 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Fresenius Medical Care Midwest Lakeshore with elevated calcium levels.
| Patients with hypercalcemia | 55 |
| Hypercalcemia patient months | 532 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 60 |
| Patients with Serumphosphor less than 3.5 mg/dL | 13 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 29 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 31 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 22 |
| Patients with Serumphosphor greater than 7 mg/dL | 5 |
News Archive
"American Hospital Association, which represents nearly 5,000 hospitals, spent $3.7 million lobbying the federal government in the first quarter on Medicare, health care reform and a host of other topics," which included "Medicare fraud prevention, a requirement for minimum nurse staffing rations for some Medicare providers and a bill that provides for the application of a consistent part B premium for all Medicare beneficiaries, according to a 34-page lobbying report filed with the clerk of the House of Representatives…
The Wall Street Journal: "After years of frustration, workers sickened in the recovery and cleanup efforts after the Sept. 11 terrorist attacks are on the verge of getting paid for their illnesses. Yet the proposed legal settlement of up to $712 million also would pay money to thousands of people who aren't sick at all. That's just one of the concerns that could scuttle the proposed deal, which requires approval of 95% of those suing for compensation."
Scientists at The Rockefeller University have mapped the three-dimensional structure for one of the more notorious disease-causing molecules in the human body: the protein responsible for the genetic disorder cystic fibrosis. And it looks fishy.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Vertex Pharmaceuticals has announced that its collaborator, GlaxoSmithKline (GSK), has received fast track designation for the HIV protease inhibitor (PI) 640385 (VX-385) from the United States Food and Drug Administration.
› Verified 2 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 30 |
| Patient months included in arterial venous fistula and catheter summaries | 263 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 52 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 26 |
News Archive
"American Hospital Association, which represents nearly 5,000 hospitals, spent $3.7 million lobbying the federal government in the first quarter on Medicare, health care reform and a host of other topics," which included "Medicare fraud prevention, a requirement for minimum nurse staffing rations for some Medicare providers and a bill that provides for the application of a consistent part B premium for all Medicare beneficiaries, according to a 34-page lobbying report filed with the clerk of the House of Representatives…
The Wall Street Journal: "After years of frustration, workers sickened in the recovery and cleanup efforts after the Sept. 11 terrorist attacks are on the verge of getting paid for their illnesses. Yet the proposed legal settlement of up to $712 million also would pay money to thousands of people who aren't sick at all. That's just one of the concerns that could scuttle the proposed deal, which requires approval of 95% of those suing for compensation."
Scientists at The Rockefeller University have mapped the three-dimensional structure for one of the more notorious disease-causing molecules in the human body: the protein responsible for the genetic disorder cystic fibrosis. And it looks fishy.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Vertex Pharmaceuticals has announced that its collaborator, GlaxoSmithKline (GSK), has received fast track designation for the HIV protease inhibitor (PI) 640385 (VX-385) from the United States Food and Drug Administration.
› Verified 2 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 37 |
| Hospitalization Rate in facility | 218.3 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 387.8 |
| Hospitalization Rate: Lower Confidence Limit | 128.5 |
News Archive
"American Hospital Association, which represents nearly 5,000 hospitals, spent $3.7 million lobbying the federal government in the first quarter on Medicare, health care reform and a host of other topics," which included "Medicare fraud prevention, a requirement for minimum nurse staffing rations for some Medicare providers and a bill that provides for the application of a consistent part B premium for all Medicare beneficiaries, according to a 34-page lobbying report filed with the clerk of the House of Representatives…
The Wall Street Journal: "After years of frustration, workers sickened in the recovery and cleanup efforts after the Sept. 11 terrorist attacks are on the verge of getting paid for their illnesses. Yet the proposed legal settlement of up to $712 million also would pay money to thousands of people who aren't sick at all. That's just one of the concerns that could scuttle the proposed deal, which requires approval of 95% of those suing for compensation."
Scientists at The Rockefeller University have mapped the three-dimensional structure for one of the more notorious disease-causing molecules in the human body: the protein responsible for the genetic disorder cystic fibrosis. And it looks fishy.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Vertex Pharmaceuticals has announced that its collaborator, GlaxoSmithKline (GSK), has received fast track designation for the HIV protease inhibitor (PI) 640385 (VX-385) from the United States Food and Drug Administration.
› Verified 2 days ago
The rate of readmission show you whether patients who were being treated regularly at Fresenius Medical Care Midwest Lakeshore were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 34.2 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 46.2 |
| Readmission Rate: Lower Confidence Limit | 23.5 |
News Archive
"American Hospital Association, which represents nearly 5,000 hospitals, spent $3.7 million lobbying the federal government in the first quarter on Medicare, health care reform and a host of other topics," which included "Medicare fraud prevention, a requirement for minimum nurse staffing rations for some Medicare providers and a bill that provides for the application of a consistent part B premium for all Medicare beneficiaries, according to a 34-page lobbying report filed with the clerk of the House of Representatives…
The Wall Street Journal: "After years of frustration, workers sickened in the recovery and cleanup efforts after the Sept. 11 terrorist attacks are on the verge of getting paid for their illnesses. Yet the proposed legal settlement of up to $712 million also would pay money to thousands of people who aren't sick at all. That's just one of the concerns that could scuttle the proposed deal, which requires approval of 95% of those suing for compensation."
Scientists at The Rockefeller University have mapped the three-dimensional structure for one of the more notorious disease-causing molecules in the human body: the protein responsible for the genetic disorder cystic fibrosis. And it looks fishy.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Vertex Pharmaceuticals has announced that its collaborator, GlaxoSmithKline (GSK), has received fast track designation for the HIV protease inhibitor (PI) 640385 (VX-385) from the United States Food and Drug Administration.
› Verified 2 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Fresenius Medical Care Midwest Lakeshore get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .24 (As Expected) |
| SIR: Upper Confidence Limit | 1.19 |
| SIR: Lower Confidence Limit | .01 |
News Archive
"American Hospital Association, which represents nearly 5,000 hospitals, spent $3.7 million lobbying the federal government in the first quarter on Medicare, health care reform and a host of other topics," which included "Medicare fraud prevention, a requirement for minimum nurse staffing rations for some Medicare providers and a bill that provides for the application of a consistent part B premium for all Medicare beneficiaries, according to a 34-page lobbying report filed with the clerk of the House of Representatives…
The Wall Street Journal: "After years of frustration, workers sickened in the recovery and cleanup efforts after the Sept. 11 terrorist attacks are on the verge of getting paid for their illnesses. Yet the proposed legal settlement of up to $712 million also would pay money to thousands of people who aren't sick at all. That's just one of the concerns that could scuttle the proposed deal, which requires approval of 95% of those suing for compensation."
Scientists at The Rockefeller University have mapped the three-dimensional structure for one of the more notorious disease-causing molecules in the human body: the protein responsible for the genetic disorder cystic fibrosis. And it looks fishy.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Vertex Pharmaceuticals has announced that its collaborator, GlaxoSmithKline (GSK), has received fast track designation for the HIV protease inhibitor (PI) 640385 (VX-385) from the United States Food and Drug Administration.
› Verified 2 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Fresenius Medical Care Midwest Lakeshore's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 28 |
| Transfusion Rate in facility | 23.5 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 137.7 |
| Transfusion Rate: Lower Confidence Limit | 5 |
News Archive
"American Hospital Association, which represents nearly 5,000 hospitals, spent $3.7 million lobbying the federal government in the first quarter on Medicare, health care reform and a host of other topics," which included "Medicare fraud prevention, a requirement for minimum nurse staffing rations for some Medicare providers and a bill that provides for the application of a consistent part B premium for all Medicare beneficiaries, according to a 34-page lobbying report filed with the clerk of the House of Representatives…
The Wall Street Journal: "After years of frustration, workers sickened in the recovery and cleanup efforts after the Sept. 11 terrorist attacks are on the verge of getting paid for their illnesses. Yet the proposed legal settlement of up to $712 million also would pay money to thousands of people who aren't sick at all. That's just one of the concerns that could scuttle the proposed deal, which requires approval of 95% of those suing for compensation."
Scientists at The Rockefeller University have mapped the three-dimensional structure for one of the more notorious disease-causing molecules in the human body: the protein responsible for the genetic disorder cystic fibrosis. And it looks fishy.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Vertex Pharmaceuticals has announced that its collaborator, GlaxoSmithKline (GSK), has received fast track designation for the HIV protease inhibitor (PI) 640385 (VX-385) from the United States Food and Drug Administration.
› Verified 2 days ago
The rate of mortality show you whether patients who were being treated regularly at Fresenius Medical Care Midwest Lakeshore lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 213 |
| Mortality Rate in facility | 12.8 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 18.6 |
| Mortality Rate: Lower Confidence Limit | 8.4 |
News Archive
"American Hospital Association, which represents nearly 5,000 hospitals, spent $3.7 million lobbying the federal government in the first quarter on Medicare, health care reform and a host of other topics," which included "Medicare fraud prevention, a requirement for minimum nurse staffing rations for some Medicare providers and a bill that provides for the application of a consistent part B premium for all Medicare beneficiaries, according to a 34-page lobbying report filed with the clerk of the House of Representatives…
The Wall Street Journal: "After years of frustration, workers sickened in the recovery and cleanup efforts after the Sept. 11 terrorist attacks are on the verge of getting paid for their illnesses. Yet the proposed legal settlement of up to $712 million also would pay money to thousands of people who aren't sick at all. That's just one of the concerns that could scuttle the proposed deal, which requires approval of 95% of those suing for compensation."
Scientists at The Rockefeller University have mapped the three-dimensional structure for one of the more notorious disease-causing molecules in the human body: the protein responsible for the genetic disorder cystic fibrosis. And it looks fishy.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Vertex Pharmaceuticals has announced that its collaborator, GlaxoSmithKline (GSK), has received fast track designation for the HIV protease inhibitor (PI) 640385 (VX-385) from the United States Food and Drug Administration.
› Verified 2 days ago
Fresenius Medical Care Midwest Lakeshore Location: 2000 E Layton Ave Ste 200, Saint Francis, Wisconsin, 53235 Phone: (414) 481-7179 |
News Archive
"American Hospital Association, which represents nearly 5,000 hospitals, spent $3.7 million lobbying the federal government in the first quarter on Medicare, health care reform and a host of other topics," which included "Medicare fraud prevention, a requirement for minimum nurse staffing rations for some Medicare providers and a bill that provides for the application of a consistent part B premium for all Medicare beneficiaries, according to a 34-page lobbying report filed with the clerk of the House of Representatives…
The Wall Street Journal: "After years of frustration, workers sickened in the recovery and cleanup efforts after the Sept. 11 terrorist attacks are on the verge of getting paid for their illnesses. Yet the proposed legal settlement of up to $712 million also would pay money to thousands of people who aren't sick at all. That's just one of the concerns that could scuttle the proposed deal, which requires approval of 95% of those suing for compensation."
Scientists at The Rockefeller University have mapped the three-dimensional structure for one of the more notorious disease-causing molecules in the human body: the protein responsible for the genetic disorder cystic fibrosis. And it looks fishy.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Vertex Pharmaceuticals has announced that its collaborator, GlaxoSmithKline (GSK), has received fast track designation for the HIV protease inhibitor (PI) 640385 (VX-385) from the United States Food and Drug Administration.
› Verified 2 days ago